paroxysmal nocturnal hemoglobinuria (PNH) | Page 26 | Aplastic Anemia & MDS International Foundation

paroxysmal nocturnal hemoglobinuria (PNH)

Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria

Rondelli T, Risitano AM, Peffault de Latour R, Sica M, Peruzzi B, Ricci P, Barcellini W, Iori AP, Boschetti C, Valle V, Frémeaux-Bacchi V, De Angioletti M, Socié G, Luzzatto L, Notaro R.
Primary Author: 
Rondelli T
Journal Title: 
Original Publication Date: 
Sep 2013

Complement blockade by

Shyamala Navada, MD

Navada, Shyamala
Assistant Professor of Medicine, Hematology and Medical Oncology
Mount Sinai Medical Center

Dr. Navada is an assistant professor in the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai in New York City.  She attended medical school at the University of Illinois at Chicago.  Subsequently, she did an Internal Medicine Residency at the University of Michigan in Ann Arbor prior to completing a hematology/oncology fellowship at Mount Sinai.  She is currently completing a Masters of Science in

The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood - a prospective study by EWOG-MDS.

Aalbers AM, van der Velden VH, Yoshimi A, Fischer A, Noellke P, Zwaan CM, Baumann I, Beverloo HB, Dworzak M, Hasle H, Locatelli F, De Moerloose B, Göhring G, Schmugge M, Stary J, Zecca M, Langerak AW, van Dongen JJ, Pieters R, Niemeyer CM, van den Heuvel
Primary Author: 
Aalbers AM
Journal Title: 
Original Publication Date: 
Jun 2013

No abstract available.